Peregrine Pharmaceuticals (PPHM) Goes Red to Green
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Join SI Premium – FREE
After trading lower earlier, Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) jumped into positive territory. Shares are now up 1 percent.
We are hearing this is related to positive commentary on today's Wedbush conference. Sources on the call said it's going "great."
Earlier, Roth Capital added the stock it to its Focus List.
Shares are up 350 percent since the end of June, mainly on the hopes for cancer drug bavituximab.
We are hearing this is related to positive commentary on today's Wedbush conference. Sources on the call said it's going "great."
Earlier, Roth Capital added the stock it to its Focus List.
Shares are up 350 percent since the end of June, mainly on the hopes for cancer drug bavituximab.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nokia to join Euro Stoxx 50 Index
- Sen. Hassan asks Capital One on closed Trump-related accounts
- White House: barrels from Venezuela deal could hit reserves in U.S. In November
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
